Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Mesenchymal Stromal Cells on the Mortality of Patients With Sepsis and Septic Shock: A Promising Therapy

NCT05283317 is registered in ClinicalTrials.gov with TC Erciyes University as lead sponsor.

NCT NCT05283317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05283317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Mesenchymal Stromal Cells on the Mortality of Patients With Sepsis and Septic Shock: A Promising Therapy
Lead sponsor
TC Erciyes University
Phase
Phase 1/2
Overall status
Completed
Start date
March 11, 2018
Completion date
November 13, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock